Literature DB >> 2001617

The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale.

J A Halikas1, K L Kuhn, R Crosby, G Carlson, F Crea.   

Abstract

Drug craving is an irresistible urge that compels drug-seeking behavior, and which often accounts for relapse among treated cocaine users. A cocaine craving scale that has proven reliable and practical in clinical treatment research with cocaine-using subjects is presented. It assesses intensity, frequency, and duration of this entirely subjective phenomenon. Data from 234 scales completed by 35 patients in treatment showed that craving for cocaine was of variable intensity, experienced relatively few times per day (zero to two), and of short duration (less than 20 minutes). Internal consistency among the three scales was robust, shown by a standardized item alpha of .826. The use of this scale should allow for each component of craving to be studied separately.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001617     DOI: 10.1016/0010-440x(91)90066-l

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  20 in total

Review 1.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

Review 2.  A model for pharmacological research-treatment of cocaine dependence.

Authors:  I D Montoya; J M Hess; K L Preston; D A Gorelick
Journal:  J Subst Abuse Treat       Date:  1995 Nov-Dec

Review 3.  A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?

Authors:  Breanne E Biondi; Xiaoying Zheng; Cynthia A Frank; Ismene Petrakis; Sandra A Springer
Journal:  Am J Addict       Date:  2020-04-29

4.  Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.

Authors:  Jennifer G Plebani; Kevin G Lynch; Qin Yu; Helen M Pettinati; Charles P O'Brien; Kyle M Kampman
Journal:  Drug Alcohol Depend       Date:  2011-09-16       Impact factor: 4.492

5.  Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.

Authors:  Marc E Mooney; Joy M Schmitz; F Gerard Moeller; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2006-11-28       Impact factor: 4.492

6.  Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.

Authors:  Jamshid Ahmadi; Kyle M Kampman; David M Oslin; Helen M Pettinati; Charles Dackis; Thorne Sparkman
Journal:  Am J Addict       Date:  2009 Jan-Feb

7.  A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment.

Authors:  R C Crist; G A Doyle; K M Kampman; W H Berrettini
Journal:  Drug Alcohol Depend       Date:  2016-07-14       Impact factor: 4.492

8.  Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence.

Authors:  I D Montoya; F R Levin; P J Fudala; D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1995-06       Impact factor: 4.492

9.  A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

Authors:  Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Kelly Spratt; Michael R Wierzbicki; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2013-06-28       Impact factor: 4.492

10.  Individual predictors of the subjective effects of intravenous cocaine.

Authors:  Kenneth Grasing; Deepan Mathur; Thomas F Newton; Cherilyn Desouza
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.